Press Releases

GI Dynamics Suspends Shipments of CE Marked Product

Company Provides Preliminary Update on Third Quarter Revenues LEXINGTON, Massachusetts – 6 October 2014 – GI Dynamics, Inc. (ASX: GID), a medical device company developing innovative treatments for type 2 diabetes and obesity, today announced that its Notified Body in the European Union, an...

read more

New Data Presented at EASD Demonstrate Robust Cardiometabolic Health Effects of EndoBarrier® Therapy in Obese People With and Without Diabetes

Pooled analysis from two studies shows significant reduction in 10-year CV risk LEXINGTON, Massachusetts & SYDNEY, Australia – 17 September 2014 – GI Dynamics, Inc. (ASX: GID), a medical device company developing innovative treatments for type 2 diabetes and obesity, today announced new data...

read more

GI Dynamics, Inc. Appoints Daniel J. Moore to the Company’s Board of Directors

LEXINGTON, Massachusetts & SYDNEY, Australia – 11 September 2014 – GI Dynamics, Inc. (ASX: GID) today announced the appointment of Daniel J. Moore, president and CEO of Cyberonics, to the company’s Board of Directors, effective today. Mr. Moore’s appointment expands the Board to seven...

read more

GI Dynamics Announces EndoBarrier® Therapy Data to be Presented at the 50th Annual Meeting of the European Association for the Study of Diabetes

LEXINGTON, Massachusetts & SYDNEY, Australia – 9 September 2014 – GI Dynamics, Inc. (ASX: GID), a medical device company developing innovative treatments for type 2 diabetes and obesity, today announced that new data on EndoBarrier® Therapy will be presented during five poster presentations at...

read more

GI Dynamics, Inc. Announces Corporate Restructuring and Departure of Chief Financial Officer

LEXINGTON, Massachusetts & SYDNEY, Australia – 8 December 2014 – GI Dynamics, Inc. (ASX: GID) a medical device company developing innovative treatments for type 2 diabetes and obesity, today announced that the Company and Robert W. Crane, its chief financial officer, secretary and treasurer,...

read more

New Clinical Data Highlighting Safety and Efficacy of EndoBarrier® Therapy Presented at the 19th World Congress of International Federation for the Surgery of Obesity and Metabolic Disorders

Data Further Demonstrate the Utility of EndoBarrier Therapy in the Treatment of Patients with Type 2 Diabetes and Obesity MONTREAL, Canada, LEXINGTON, United States and SYDNEY, Australia – 29 August 2014 – GI Dynamics, Inc. (ASX: GID), a medical device company developing innovative treatments for...

read more

GI Dynamics, Inc. Announces the Appointment of Medical Device Industry Veteran Michael D. Dale as President & Chief Executive Officer

Stuart A. Randle to Step Down from CEO Role  LEXINGTON, Massachusetts & SYDNEY, Australia – 28 August 2014 – GI Dynamics, Inc. (ASX: GID) today announced the appointment of Michael D. Dale as President, CEO and member of the Board of Directors of GI Dynamics, effective September 18, 2014. Mr....

read more

GI Dynamics to Present at the 34th Annual Canaccord Genuity Growth Conference

LEXINGTON, Massachusetts & SYDNEY, Australia – 7 August 2014 – GI Dynamics, Inc. (ASX: GID), a medical device company developing innovative treatments for type 2 diabetes and obesity, today announced that Stuart A. Randle, president and chief executive officer, will preseant at the 34th Annual...

read more

Appendix 4C Quarterly Report Quarter ended 30 June 2014

GI Dynamics to Hold Briefing Call and Webcast on Financial Results for Second Quarter 2014 on Monday, 4 August 2014 at 6 p.m. U.S. EDT  / Tuesday, 5 August 2014 at 8 a.m. AEST     LEXINGTON, Massachusetts, United States and SYDNEY, Australia – 31 July 2014 – GI Dynamics, Inc. (ASX: GID) (GI...

read more

GI Dynamics Announces Launch of EndoBarrier® Therapy Clinical Utility Study in France

LEXINGTON, Massachusetts & SYDNEY, Australia – 30 July 2014 – GI Dynamics, Inc. (ASX: GID) today announced that the first patients have been enrolled in a large, randomized, multi-center, clinical utility study of EndoBarrier® Therapy (ENDOMETAB), sponsored by the French Ministry of Social...

read more
Page 5 of 10« First...34567...10...Last »